FOI Request
- Disclosure ID
- FOI/00945
- Request Date
- May 4, 2016
- Subject
- Vials/Implants
- Description
Dear Sir Within your trust how many intra-vitreal vials/implants have been used in the latest 4 months, if possible between January to April 2016
Please state the number of vials dispensed from your pharmacy in this period, if the number for wet AMD is not known, then regardless of reason for use. Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants Total Vials / Implants Vials / Impants for Wet Age Related Macular Degeneration (wAMD)
- Response
Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants Total Vials / Implants Vials / Impants for Wet Age Related Macular Degeneration (wAMD) 967 78 752 0 25 The Bevacizumab that was used was not used for Wet AMD treatment.